Class 1 recall-Emerade 300 & 500 Auto-Injectors

reason: Pharmaswiss Česka republika s.r.o. and distributor Bausch & Lomb UK Limited is recalling all unexpired batches of Emerade 500 micrograms and Emerade 300 micrograms adrenaline auto-injectors (also referred to as pens) from patients. This is due to an issue identified during an ISO 11608 Design Assessment study where some auto-injectors failed to deliver the product or activated prematurely

MHRA drug alert date  9th May 2023

MHRA ref: MDR 020-05/23

Further Information

For stock enquiries, please contact Bausch & Lomb Customer Services:

Tel: 020 8781 2991

Email: Pharma_CS@bausch.com

For medical information enquiries please contact the Medical Information Team:

Email: medinfo.europe@bauschhealth.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.